Riskpilot← Back to searchSign inGet full accessKansei AB
ABActiveOrg 5592849631Ynglingagatan 17Physiotherapy activities · NACE 8695Est. 20200 employees
Revenue 2024
SEK 67K
-39% vs 2023
EBITDA margin
-61.5%
+90% vs 2023
Equity ratio
91.4%
Financial strength
Net profit 2024
SEK -90K
+81% vs 2023
| Revenue | SEK 67K | -39% |
| EBITDA | SEK -41K | +90% |
| Net profit | SEK -90K | +81% |
| Total assets | SEK 13,8M | +0% |
| Equity | SEK 12,6M | -1% |
| Employees | 0 | — |
Legal name
Kansei AB
Org number
5592849631
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
24 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva verksamhet inom områdena naprapati, manuell medicin, akupunktur, träning, kostrådgivning, hälsorådgivning, hälsa och friskvård. Företaget ska även bedriva forskning, föreläsningar, utbildningar, konsultverksamhet och bemanningsverksamhet inom områdena naprapati och hälsa samt därmed förenlig verksamhet.
Address
Ynglingagatan 17
Email
carlrobert.karell@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 11 | 46 | 109 | 67 |
| Staff expenses | — | — | −14 | −0 |
| EBITDA | 7 | −213 | −416 | −41 |
| Depreciation & amort. | −0 | −20 | −50 | −50 |
| EBIT | 7 | −232 | −466 | −91 |
| Net financials | — | — | −0 | 0 |
| Profit before tax | 6 | −232 | −466 | −90 |
| Tax | −1 | — | — | — |
| Net profit | 5 | −232 | −466 | −90 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 32 | 3 437 | 13 852 | 13 822 |
| Equity | 30 | 3 415 | 12 717 | 12 626 |
| Long-term debt | 0 | — | — | 73 |
| Short-term debt | 1 | 21 | 1 135 | 1 123 |
| Total debt | 1 | 21 | 1 135 | 1 195 |
EBITDA margin
-61.5%
This company
15.8%
Market median
-489% vs market
20212024
Equity ratio
91.4%
This company
38.2%
Market median
+139% vs market
20212024
Return on equity
-0.7%
This company
18.4%
Market median
-104% vs market
20212024
Net profit margin
-135.5%
This company
8.1%
Market median
-1773% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kansei AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Gustaf Kårell | Deputy Board Member | 0 companies |
| Carl-Robert Kårell Holmer | Board of Directors | 0 companies |